Amorfix perfect testing vCJD France

Amorfix Life Sciences (TSX:AMF) has achieved 100% specificity, or no reproducible false positive results, after testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease, the human version of mad cow disease, with its EP-vCJD blood-screening assay in France. “Our France study has demonstrated the feasibility of implementing the Amorfix test and has provided confidence that very [...]

Amorfix detects vCJD prions in non-human primates

Amorfix Life Sciences (TSX:AMF) has taken a giant step in readying a screening test for the human version of mad cow disease by reporting that it detected abnormal proteins or prions responsible for the disease in monkey blood. “It’s fantastic for our test,” George Adams, CEO of Amorfix, told Andy Georgiades of Dow Jones newservice, [...]